- Filed
- Sep 2, 2025
- Last modified
- Mar 24, 2026
- Petitioner
- Clean Chemistry, Inc.
- Inventor
- Michael S. Harvey et al
Patent 9363997
PTAB challenges
AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.
Active provider: Google · gemini-2.5-flash
Proceedings on file (1)
All PTAB activity →AIA trial proceedings (IPR / PGR / CBM) filed at the USPTO Patent Trial and Appeal Board against this patent. Sourced from the USPTO Open Data Portal and refreshed every six hours; each proceeding number deep-links to the PTAB E2E docket.
Current assignee: Clean Chemistry, Inc.
PTAB challenges
AIA trial proceedings at the USPTO Patent Trial and Appeal Board — IPR, PGR, and CBM. Petitioners, judge panels, claim-level invalidation outcomes from Final Written Decisions, and Federal Circuit appeals. The single most important defensive datapoint after litigation history.
Proceedings overview
One AIA trial proceeding has been filed against US patent 9363997. This proceeding resulted in a discretionary denial of institution, meaning no claims were challenged on the merits and the patent's claims remain untested by PTAB review. This posture indicates that the patent has not yet faced a full challenge at the PTAB, but a prior attempt by Clean Chemistry, Inc. was denied institution.
IPR2025-01471 — Clean Chemistry, Inc. v. Enviro Tech Chemical Services Inc
- Type: Inter Partes Review
- Filed: 2025-09-02
- Status: Discretionary Denial — The PTAB declined to institute review based on a procedural ground, rather than on the merits of the prior art challenge.
- Judge panel: Not publicly available at this stage for a discretionary denial.
- Petition grounds: Details not specified in the provided data. Based on the "Discretionary Denial" status, the merits of the claims under § 102 / § 103 were likely not fully assessed in the decision to deny.
- Institution decision: Denied (Discretionary Denial) — The petition was denied institution on 2026-03-24. The reasoning for a discretionary denial often relates to factors like parallel district court litigation, timing of the petition, or efficiency concerns, rather than the petitioner's likelihood of success on the merits.
- Final Written Decision: Not issued, as institution was denied.
- Settlement / termination: Terminated via discretionary denial.
- Appeal: No Federal Circuit appeal related to the merits of the patent claims, as institution was denied.
- Defensive value: This proceeding indicates that Clean Chemistry, Inc. attempted to challenge the patent but was unsuccessful in getting the IPR instituted. While the claims were not upheld on the merits, they were also not invalidated. This means the patent's claims remain as granted by the USPTO, and a defendant would need to consider a new IPR petition if they wished to challenge the patent through this avenue.
Strategic summary
Currently, all claims of US9363997 remain SUSTAINED as they have not been subjected to a full merits review at the PTAB. The single IPR filed, IPR2025-01471, was denied institution on discretionary grounds, meaning the PTAB did not reach the merits of the prior art arguments against the patent's claims. Therefore, no claims have been canceled or deemed unpatentable by the PTAB.
The estoppel landscape for IPR2025-01471 is complex due to the discretionary denial. Generally, a petitioner is estopped under 35 U.S.C. § 315(e)(2) only if a Final Written Decision is issued. However, the Federal Circuit's Arthrex decision and subsequent guidance suggest that even certain types of discretionary denials (e.g., Sotera Wireless, Inc. v. Masimo Corp.) can lead to estoppel for the petitioner (Clean Chemistry, Inc.) regarding grounds that were raised or reasonably could have been raised. For other potential defendants, however, the full range of prior-art grounds under § 102 and § 103 remain available to challenge the patent's claims in a new IPR, as no merits decision was rendered in IPR2025-01471.
There is no clear pattern of aggressive PTAB appeals by the patent owner, nor has the same petitioner filed multiple IPRs on this patent based on the provided data. Unified Patents is listed as a petitioner in an IPR on this patent family (IPR2025-01471), suggesting potential defensive aggregation activity.
Recommended next steps
- Given the discretionary denial in IPR2025-01471, a potential defendant should review the specific reasoning for the denial in the institution decision to understand the procedural hurdles encountered by the previous petitioner, Clean Chemistry, Inc.
- As all claims of US9363997 remain unchallenged on the merits at the PTAB, a defendant facing assertion of this patent may consider filing a new IPR petition. The absence of a prior merits-based decision means that prior art grounds are still open for review by the PTAB for a new petitioner (assuming no privity with Clean Chemistry, Inc.).
- Monitor the patent's litigation history for any parallel district court proceedings that might influence future PTAB filings or vice-versa.
Generated 5/23/2026, 12:46:24 PM